Solta Medical, Inc. has announced it has received FDA 510(k) clearance of its Fraxel re:store®Dual for the treatment of actinic keratosis (AKs). The Fraxel re:store Dual system takes the industry leading fractional laser technology to the next level by adding a novel 1927 nm wavelength, the first ever application of a Thulium laser in the aesthetics market. The Fraxel re:store Dual treatment provides superior results for the removal of AKs.

Read the full story here

SurgiCount Medical has announced that it has signed a contract with Kalispell Regional Medical Center to implement the SurgiCount Safety-Sponge® System, a proven solution to prevent one of the most common surgical errors, retained surgical sponges. The first hospital in the State of Montana to adopt the SurgiCount solution, Kalispell Regional Medical Center joins a prestigious list of over 50 user hospitals including 5 of U.S. News and World Report’s 2010-2011 Honor Roll Hospitals.

Read the full story here

ConvaTec has announced the introduction of a new, narrower size of AQUACEL® and AQUACEL® Ag Ribbon Dressings with Strengthening Fibers, now available in the U.S. and select European countries for the management of moderate to highly exuding chronic and acute wounds. The new dressing, half the width of the currently available dressing, is designed specifically for use in excised abscesses and smaller wounds that tunnel below the wound surface.

Read the full story here

Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University (UGent) have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs. The NF-kB protein plays a critical role in the inflammatory response and is activated by e.g. TNF, which is produced by the white blood cells.

Read the full story here

“410B,” a new style of breast implant, could reduce healing time and ease pain. Although it is not yet approved by the FDA, the plastic surgeon who created it calls it the “most studied breast implant ever.” Also known as the ‘Gummy Bear Implant,’ the product is the only implant in history that stimulated the development of techniques that let people recover in 24 hours and go out for dinner on the night of surgery, Plastic Surgeon John Tebbetts said proudly.

Light BioScience LLC has received a 510(k) over-the-counter (OTC) clearance from the FDA for its GentleWaves LED Photomodulation technology. The LED (light emitting diode) based, anti-wrinkle treatment is already being used by physicians to reduce the appearance of fine lines and wrinkles. The company claims that the technology helps to stimulate collagen production as well as to slow down collagen breakdown. Light BioScience can now develop a device that can be sold without a prescription.